
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Drug Development for Gene Therapy Industry-centric perspective on translational and bioanalytical challenges and best practices for gene therapies Drug Development for Gene Therapy focuses on the translational and bioanalytical challenges and best practices for gene therapy modalities, presenting a significant body of data, including information related to safety and efficacy, necessary to advance through the development pipeline into clinical use. The text covers bioanalytical methods and platforms including patient screening assays, different PCR tests, enzyme activity assays, ELISpot, NGS, LC/MS, and immunoassays, with FDA and EMA guidelines on gene therapy safety and efficacy, along with companion diagnostics regulations from US and EU perspectives. The chapters offer an in-depth discussion of the basics and best practices for translational biomarkers, bioanalysis, and developing companion diagnostics / lab tests for gene therapies in the pharma and biopharma industries. To aid in reader comprehension, the text includes clinical examples of relevant therapies in related chapters. Some of the core topics covered include study design, immunogenicity, various bioanalytical methods and their applications, and global regulatory issues. Written by two highly qualified authors with significant experience in the field, Drug Development for Gene Therapy includes information on: Bioanalytical methods to detect pre-existing antibodies against adeno-associated viruses (AAV) capsids Detection of cellular immunity and humoral response to viral capsids and transgene proteins, and immunogenicity of gene therapy products Nonclinical and clinical study considerations and methods for biodistribution and shedding Quantification of transgene protein expression and biochemical function, and substrate and distal pharmacodynamic biomarker measurements for gene therapy Detection and quanti
This book addresses the critical translational and bioanalytical challenges inherent in developing gene therapies for clinical use. It provides an industry-centric perspective, detailing the data, safety, and efficacy information required to advance these novel treatments. The text covers a range of bioanalytical methods and platforms, regulatory guidelines from the FDA and EMA, and the development of companion diagnostics from both US and EU viewpoints, aiming to equip professionals in the pharma and biopharma industries.
This comprehensive text is written by two highly qualified authors with significant experience in the field, offering an industry-centric perspective on gene therapy development. It is structured to provide professionals with the essential data and best practices needed to navigate the complex pipeline from research to clinical application. The inclusion of clinical examples and detailed discussions on regulatory frameworks aims to make it a valuable resource for those working in pharmaceutical and biopharmaceutical research and development.
Page Count:
496
Publication Date:
2024-02-09
Publisher:
Wiley
ISBN-10:
1119852803
ISBN-13:
9781119852803
No comments yet. Be the first to share your thoughts!